Article Sidebar
Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Formulation and characterization of norethisterone transdermal patch as an alternative route to oral administration
Abstract
Purpose: To design a transdermal norethisterone (NE) patch for controlled drug release Methods: Polymers, viz, sodium salt of carboxymethyl cellulose (CMCNa) and hydroxyethyl cellulose (HEC), as well as a plasticizer (propylene glycole, PG) were used at various ratios to prepare NE films. The drug was dispersed in water and mixed with the polymer gel/plasticizer mixture prior to film casting. Weight variation, thickness, tensile strength, and the interaction between drug and film excipient were evaluated. The films were also characterized by Fourier transform infrared spectroscopy (FT–IR). In vitro drug dissolution and release from the transdermal patches (coded C–L, C–T, H–L and H–T) were evaluated.
Results: There was significant difference between the batches in terms of in vitro drug release (p > 0.05). Dissolved drug was significantly higher in H-T film when compared to C-L film (p < 0.05). İn addition, drug release was significantly higher from H-T patch than from C-L patch (p < 0.05). Conclusion: NE transdermal patches containing HEC and Transcutol® have been successfully formulated. They can potentially be used to deliver NE via transdermal route to decrease the side effects associated with the oral route of administration of the hormone.
Keywords: Norethisterone, Transdermal delivery, Controlled release, Hormone therapy
